Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Intrinsic Value
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. [ Read More ]
The intrinsic value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock under the Base Case scenario is 22.74 CNY. Compared to the current market price of 31.21 CNY, Shenzhen Salubris Pharmaceuticals Co Ltd is Overvalued by 27%.
Valuation Backtest
Shenzhen Salubris Pharmaceuticals Co Ltd
Run backtest to discover the historical profit from buying and selling Shenzhen Salubris Pharmaceuticals Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Shenzhen Salubris Pharmaceuticals Co Ltd
| Current Assets | 3.3B |
| Cash & Short-Term Investments | 2.2B |
| Receivables | 578.6m |
| Other Current Assets | 532.6m |
| Non-Current Assets | 6.1B |
| Long-Term Investments | 1.7B |
| PP&E | 1.5B |
| Intangibles | 2.6B |
| Other Non-Current Assets | 266.4m |
| Current Liabilities | 815.1m |
| Accounts Payable | 156m |
| Accrued Liabilities | 491.3m |
| Short-Term Debt | 42.6m |
| Other Current Liabilities | 125.2m |
| Non-Current Liabilities | 562.6m |
| Long-Term Debt | 12.5m |
| Other Non-Current Liabilities | 550.1m |
Earnings Waterfall
Shenzhen Salubris Pharmaceuticals Co Ltd
|
Revenue
|
3.4B
CNY
|
|
Cost of Revenue
|
-1.1B
CNY
|
|
Gross Profit
|
2.3B
CNY
|
|
Operating Expenses
|
-1.7B
CNY
|
|
Operating Income
|
630.2m
CNY
|
|
Other Expenses
|
-50.1m
CNY
|
|
Net Income
|
580.1m
CNY
|
Free Cash Flow Analysis
Shenzhen Salubris Pharmaceuticals Co Ltd
Profitability Score
Profitability Due Diligence
Shenzhen Salubris Pharmaceuticals Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Shenzhen Salubris Pharmaceuticals Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shenzhen Salubris Pharmaceuticals Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Shenzhen Salubris Pharmaceuticals Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shenzhen Salubris Pharmaceuticals Co Ltd
According to Wall Street analysts, the average 1-year price target for Shenzhen Salubris Pharmaceuticals Co Ltd is 37.74 CNY with a low forecast of 33.33 CNY and a high forecast of 43.05 CNY.
Shareholder Return
Price
Shenzhen Salubris Pharmaceuticals Co Ltd
| Average Annual Return | 13.27% |
| Standard Deviation of Annual Returns | 26.64% |
| Max Drawdown | -50% |
| Market Capitalization | 34.1B CNY |
| Shares Outstanding | 1 114 816 535 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. The company is headquartered in Shenzhen, Guangdong and currently employs 3,236 full-time employees. The company went IPO on 2009-09-10. The firm provides two categories of products: pharmaceutical preparation and bulk drugs. The firm is also engaged in the research and development, production and sales of cardiovascular medical devices. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock under the Base Case scenario is 22.74 CNY.
Compared to the current market price of 31.21 CNY, Shenzhen Salubris Pharmaceuticals Co Ltd is Overvalued by 27%.
You don't have any saved screeners yet
